Equities research analysts expect that Natus Medical Incorporated (NASDAQ:NTUS) will announce earnings of $0.38 per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Natus Medical’s earnings, with the lowest EPS estimate coming in at $0.37 and the highest estimate coming in at $0.38. Natus Medical posted earnings per share of $0.40 during the same quarter last year, which indicates a negative year over year growth rate of 5%. The firm is expected to issue its next quarterly earnings report on Wednesday, October 23rd.

According to Zacks, analysts expect that Natus Medical will report full year earnings of $1.28 per share for the current fiscal year, with EPS estimates ranging from $1.27 to $1.28. For the next fiscal year, analysts expect that the business will post earnings of $1.72 per share, with EPS estimates ranging from $1.68 to $1.76. Zacks’ EPS averages are a mean average based on a survey of analysts that that provide coverage for Natus Medical.

Natus Medical (NASDAQ:NTUS) last issued its quarterly earnings data on Thursday, July 25th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.04. The business had revenue of $125.54 million during the quarter, compared to the consensus estimate of $122.85 million. Natus Medical had a negative net margin of 7.38% and a positive return on equity of 10.73%.

Separately, Zacks Investment Research downgraded shares of Natus Medical from a “buy” rating to a “hold” rating in a research report on Friday, August 9th.

Shares of Natus Medical stock traded up $0.61 during trading hours on Friday, reaching $30.88. The stock had a trading volume of 166,100 shares, compared to its average volume of 252,531. The company has a market cap of $1.07 billion, a P/E ratio of 21.75 and a beta of 0.63. Natus Medical has a twelve month low of $22.25 and a twelve month high of $37.45. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.36 and a current ratio of 1.93.

About Natus Medical

Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.

Featured Story: Quick Ratio

Get a free copy of the Zacks research report on Natus Medical (NTUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.